Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
出版年份 2021 全文链接
标题
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
作者
关键词
-
出版物
Frontiers in Medicine
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-26
DOI
10.3389/fmed.2021.642296
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps
- (2021) Marcelo Barreto Lopes et al. Scientific Reports
- Ferroterapia en el manejo de la anemia en la enfermedad renal crónica no en diálisis: perspectiva del grupo de anemia de la S.E.N
- (2021) Aleix Cases et al. NEFROLOGIA
- Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
- (2020) Elizabeth Katherine Batchelor et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
- (2020) Steven Fishbane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
- (2020) Iain C. Macdougall et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
- (2020) Marie Evans et al. Clinical Kidney Journal
- Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
- (2020) Tadao Akizawa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MO001ROXADUSTAT FOR THE TREATMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS: A PHASE 3, RANDOMISED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY
- (2020) Jonathan Barratt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
- (2020) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
- (2020) Piotr Ponikowski et al. LANCET
- Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
- (2019) Yusuke Sakaguchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with pre-dialysis chronic kidney disease
- (2019) Monique E. Cho et al. KIDNEY INTERNATIONAL
- Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
- (2019) Nan Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
- (2019) Nan Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study
- (2019) Tadao Akizawa et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial
- (2019) Francesco Locatelli et al. Clinical Journal of the American Society of Nephrology
- The multifaceted role of iron in renal health and disease
- (2019) Rachel P. L. van Swelm et al. Nature Reviews Nephrology
- Anemia of Inflammation
- (2019) Tomas Ganz NEW ENGLAND JOURNAL OF MEDICINE
- Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated
- (2019) Michelle M Y Wong et al. Clinical Kidney Journal
- Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease
- (2019) Ahmed A Awan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The noblesse of kidney physiology
- (2019) Kai-Uwe Eckardt KIDNEY INTERNATIONAL
- Safety of Intravenous Iron in Dialysis
- (2018) Ingrid Hougen et al. Clinical Journal of the American Society of Nephrology
- Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
- (2018) Michele F. Eisenga et al. BMC Nephrology
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
- (2018) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and Hypoxia: HIF and PHD Isoform Selectivity
- (2018) Emily R. Watts et al. TRENDS IN MOLECULAR MEDICINE
- Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study
- (2018) Guy Rostoker et al. EBioMedicine
- Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
- (2018) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD
- (2017) Guus A. M. Kortman et al. Hemodialysis International
- Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
- (2017) Gregory D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- (2017) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Microbiota intestinal en la enfermedad renal crónica
- (2017) Secundino Cigarran Guldris et al. NEFROLOGIA
- Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis
- (2017) Richard Holman et al. NEPHROLOGY
- Physiological Effects of Chronic Hypoxia
- (2017) John B. West NEW ENGLAND JOURNAL OF MEDICINE
- Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
- (2016) Robert Provenzano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
- (2016) R. Provenzano et al. Clinical Journal of the American Society of Nephrology
- Inflammation and Progression of CKD: The CRIC Study
- (2016) R. L. Amdur et al. Clinical Journal of the American Society of Nephrology
- Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
- (2016) Elke Marsch et al. EUROPEAN HEART JOURNAL
- Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials
- (2016) Ewa A. Jankowska et al. EUROPEAN JOURNAL OF HEART FAILURE
- Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
- (2016) Mun Chiang Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose
- (2015) Susann Neiser et al. BIOMETALS
- Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron
- (2015) Jorge E. Toblli et al. Heart Lung and Circulation
- Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling
- (2015) T. Souma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
- (2015) K. Umanath et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
- (2014) P. Ponikowski et al. EUROPEAN HEART JOURNAL
- The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences
- (2014) IJsbrand T. Klip et al. EUROPEAN JOURNAL OF HEART FAILURE
- HIF Transcription Factors, Inflammation, and Immunity
- (2014) Asis Palazon et al. IMMUNITY
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- (2014) Melissa E. Stauffer et al. PLoS One
- The regulation of iron transport
- (2013) David M. Frazer et al. BIOFACTORS
- Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
- (2013) Gerasimos Filippatos et al. EUROPEAN JOURNAL OF HEART FAILURE
- Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
- (2013) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
- (2013) Iain C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
- (2013) José Portolés et al. BMC Nephrology
- Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
- (2012) Guy Rostoker et al. AMERICAN JOURNAL OF MEDICINE
- Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients
- (2012) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Foreword
- (2012) Kidney International Supplements
- Chronic IFN- production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis
- (2011) S. F. Libregts et al. BLOOD
- Endogenous Erythropoietin and the Association with Inflammation and Mortality in Diabetic Chronic Kidney Disease
- (2011) M. Wagner et al. Clinical Journal of the American Society of Nephrology
- A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
- (2011) Markus R. Jahn et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
- (2011) K. L. Johansen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Do two intravenous iron sucrose preparations have the same efficacy?
- (2011) J. Rottembourg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice
- (2011) Xiaoqing Pan et al. PLoS One
- Prolyl Hydroxylase Domain (PHD) 2 Affects Cell Migration and F-actin Formation via RhoA/Rho-associated Kinase-dependent Cofilin Phosphorylation
- (2010) Sabine Vogel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
- (2009) Shravanthi R. Gandra et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Hypoxia-Inducible Factor 2 Regulates Hepatic Lipid Metabolism
- (2009) E. B. Rankin et al. MOLECULAR AND CELLULAR BIOLOGY
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
- (2009) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD
- (2008) M. A. Brookhart et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease
- (2008) N. D. Vaziri et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)
- (2008) F. Locatelli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Epidemiology of Chronic Kidney Disease in Heart Failure
- (2008) Ali Ahmed et al. Heart Failure Clinics
- Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion
- (2007) Elisabeth L. Pagé et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
- (2007) Karien van der Putten et al. Nature clinical practice. Nephrology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started